Recent Finacing
Recent Raise
PaxVax develops and manufactures oral, adenoviral-based vaccines, including Vivotif (oral typhoid) and a Phase 3 oral cholera candidate, with R&D and GMP sites in the US and Switzerland.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
